Get started
Author

H. U. Schorlemmer

Observed names: H SCHORLEMMER, H Schorlemmer, H U SCHORLEMMER, H U Schorlemmer, H. -U. Schorlemmer, H. Schorlemmer, H. U. SCHORLEMMER, H.-U. Schorlemmer, H.-U. schorlemmer, H.U Schorlemmer, H.U. SCHORLEMMER, H.U. Schorlemmer, HANS U. SCHORLEMMER, HANS ULRICH SCHORLEMMER, Hans U. Schorlemmer, Hans-U. Schorlemmer
Observed institutions: University of Cape Town, Philipps University of Marburg, University of Milan, University of Veterinary Medicine Hannover, Foundation, Johannes Gutenberg University Mainz, LMU Klinikum, Behringwerke (Germany), Hoechst Marion Roussel (United States), Ludwig-Maximilians-Universität München, Deutsche Forschungsgemeinschaft, Medical Research Council
OpenAlex ID: A5111919447
Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection
1991 · R. R. Bartlett, M. Dimitrijevic, et al. · Inflammation Research · 188
Zymosan—Induced Arthritis
1977 · E. C. Keystone, H. U. Schorlemmer, et al. · Arthritis & Rheumatism · 166
Effects of activated complement components on enzyme secretion by macrophages.
1976 · H U Schorlemmer, A C Allison · PubMed Central · 164
Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.
1977 · H U Schorlemmer, D Bitter-Suermann, et al. · PubMed Central · 128
Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects.
1978 · J Ferluga, H U Schorlemmer, et al. · PubMed Central · 112
Further link between complement activation and blood coagulation
1977 · H. PRYDZ, A. C. ALLISON, et al. · Nature · 91
The role of macrophage activation in chronic inflammation
1978 · A. C. Allison, J. Ferluga, et al. · Inflammation Research · 84
The selective release of lysosomal acid hydrolases from mouse peritoneal macrophages by stimuli of chronic inflammation.
1977 · H U Schorlemmer, P Davies, et al. · PubMed Central · 73
Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
1983 · H U Schorlemmer, K Bosslet, et al. · PubMed · 72
Macrophage responses to mouldy hay dust, Micropolyspora faeni and zymosan, activators of complement by the alternative pathway.
1977 · H U Schorlemmer, J H Edwards, et al. · PubMed Central · 69
Interactions between Entamoeba histolytica and complement
1979 · G. HULDT, P. DAVIES, et al. · Nature · 59
In vivo labelling of granulocytes with 99mTc anti-NCA monoclonal antibodies for imaging inflammation
1988 · K. Joseph, H. H�ffken, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 54
Dextran sulphate: a synthetic activator of C3 via the alternative pathway. I. Influence of molecular size and degree of sulphation on the activation potency.
1975 · R Burger, U Hadding, et al. · PubMed Central · 51
Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent.
1991 · C C Küchle, G H Thoenes, et al. · PubMed · 49
Cytolytic effects of the complement cleavage product, C3a
1976 · J Ferluga, H U Schorlemmer, et al. · British Journal of Cancer · 46
PDF
15-deoxyspergualin for Induction of Graft Nonreactivity After Cardiac and Renal Allotransplantation in Primates
1990 · HERMANN REICHENSPURNER, ANDREAS HILDEBRANDT, et al. · Transplantation · 42
Activation of Complement by the Alternative Pathway as a Factor in the Pathogenesis of Periodontal Disease
1976 · A.C. Allison, H.U. Schorlemmer, et al. · The Lancet · 42
Decrease of mononuclear phagocyte cell functions and prolongation of graft survival in experimental transplantation by (±)-15-deoxyspergualin
1987 · G. Dickneite, H.U. Schorlemmer, et al. · International Journal of Immunopharmacology · 39
Induction of lysosomal enzyme release from cultured macrophages by dextran sulfate
1977 · H.U. Schorlemmer, R. Burger, et al. · Clinical Immunology and Immunopathology · 39
Ability of the T cell‐replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation
1973 · U. Hadding, M. Dierich, et al. · European Journal of Immunology · 39
A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells
1986 · K. Bosslet, H.F. Kern, et al. · Cancer Immunology Immunotherapy · 35
Cefodizime, an aminothiazolyl cephalosporin. IV. Influence on the immune system.
1984 · MICHAEL LIMBERT, ROBERT R. BARTLETT, et al. · The Journal of Antibiotics · 34
PDF
Cartilage specific collagen activates macrophages and the alternative pathway of complement: evidence for an immunopathogenic concept of rheumatoid arthritis.
1982 · H.M Hanauske-Abel, B.F Pontz, et al. · Annals of the Rheumatic Diseases · 33
PDF
Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative.
1993 · H U Schorlemmer, F R Seiler, et al. · PubMed · 32
Die Bedeutung der Mikrozirkulation bei der Absto�ung frei transplantierter Langerhans Inseln
1991 · D. Menger, B. Wolf, et al. · Langenbeck s Archives of Surgery · 32
Works count: 133
Citation count: 2,580
H-index: 29
I10-index: 58
Year
Topic
Type